share_log

Positive Earnings Growth Hasn't Been Enough to Get Hubei Kailong Chemical Group (SZSE:002783) Shareholders a Favorable Return Over the Last Three Years

Positive Earnings Growth Hasn't Been Enough to Get Hubei Kailong Chemical Group (SZSE:002783) Shareholders a Favorable Return Over the Last Three Years

在過去三年中,正收益增長不足以讓湖北開龍化工集團(SZSE:002783)股東獲得豐厚的回報
Simply Wall St ·  02/26 02:51

This week we saw the Hubei Kailong Chemical Group Co., Ltd. (SZSE:002783) share price climb by 14%. If you look at the last three years, the stock price is down. But on the bright side, its return of -17%, is better than the market, which is down 20%.

本週,凱龍股份(SZSE:002783)股價上漲14%。如果您查看過去三年,股價已下跌。但好消息是,其回報率爲-17%,優於市場,市場下跌20%。

Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline.

儘管過去一週對股東來說更令人放心,但在過去的三年中,他們仍然處於虧損狀態,因此讓我們看看基本業務是否對下降負責。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

雖然市場是一個強大的定價機制,但股價反映了投資者情緒,不僅僅是基本業績。一種有缺陷但合理的評估公司周圍情緒如何變化的方法是將每股收益(EPS)與股價進行比較。

During five years of share price growth, Hubei Kailong Chemical Group moved from a loss to profitability. That would generally be considered a positive, so we are surprised to see the share price is down. So it's worth looking at other metrics to try to understand the share price move.

在股價增長的五年中,凱龍股份從虧損轉爲盈利。這通常被認爲是一個積極的信號,因此我們對股價下跌感到驚訝。因此,值得關注其他指標,以了解股價的走勢。

With a rather small yield of just 1.2% we doubt that the stock's share price is based on its dividend. We note that, in three years, revenue has actually grown at a 20% annual rate, so that doesn't seem to be a reason to sell shares. This analysis is just perfunctory, but it might be worth researching Hubei Kailong Chemical Group more closely, as sometimes stocks fall unfairly. This could present an opportunity.

由於該股的收益率只有1.2%,我們懷疑股價並非基於其股息。我們注意到,在三年中,營收實際上以20%的年增長率增長,因此這似乎不是出售股票的原因。這個分析只是例行公事,但研究凱龍股份是否值得更仔細,因爲有時股票不公平下跌,這可能是一個機會。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。

earnings-and-revenue-growth
SZSE:002783 Earnings and Revenue Growth February 26th 2024
SZSE:002783收益和營收增長2024年2月26日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on Hubei Kailong Chemical Group's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

值得注意的是,該公司的CEO的薪酬低於類似規模公司的中位數。但是,儘管CEO的報酬值得檢查,但真正重要的問題是公司未來能否增加盈利。如果您想進一步調查該股票,凱龍股份的收益,營收和現金流的這份免費交互式報告是一個很好的起點。

A Different Perspective

不同的觀點

While it's never nice to take a loss, Hubei Kailong Chemical Group shareholders can take comfort that , including dividends,their trailing twelve month loss of 14% wasn't as bad as the market loss of around 17%. Longer term investors wouldn't be so upset, since they would have made 1.8%, each year, over five years. In the best case scenario the last year is just a temporary blip on the journey to a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Hubei Kailong Chemical Group is showing 3 warning signs in our investment analysis , and 2 of those are a bit unpleasant...

雖然虧損從來不是一件愉快的事情,但凱龍股份的股東們可以感到欣慰,因爲在包括股息在內的過去12個月中,他們的虧損14%不如市場下跌17%那樣糟糕。長期投資者不會那麼沮喪,因爲他們每年將獲得1.8%的回報率,持有5年。在最理想的情況下,過去一年只是通往更光明未來的旅程中的暫時問題。我認爲長期的股價是業務績效的一個代理。但要真正獲得洞察力,我們還需要考慮其他信息。即便如此,艾衛公司提示您,凱龍股份在我們的投資分析中顯示出3個警告信號,其中2個有點不愉快...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論